Conferences

2017 Conferences
SMi Biosimilars North America 2017 explores novel and innovative strategies to advance biosimilar development, ensure optimal market access and commercialization, and comply with evolving regulatory requirements. 
The American College of Rheumatology's Annual Meeting is the world's premier rheumatology meeting. With over 450 educational sessions, the meeting provides opportunities for professional development and access to the latest rheumatology research and clinical applications.
The 2-day conference, Leading on Biosimilars, features presentations from key industry leaders, government agency officials, and academic experts. The interactive conference provides the opportunity to learn the most up-to-date information regarding regulatory, reimbursement, legal, political, and policy environments surrounding access to biosimilar products. 
The ESMO 2017 Congress, in partnership with the European Association for Cancer Research (EACR), will bring cancer researchers and clinicians together to enable collaboration and the exchange of ideas, from the laboratory to the bedside and back. This exciting partnership creates a unique cancer congress in Europe with huge scientific reach and the true potential to improve the lives of cancer patients.
The American Diabetes Association (ADA) will present its 77th Scientific Sessions from June 9-13, 2017, in San Diego, California. More than 13,000 international attendees will convene to learn about the most significant advances in diabetes care and research during this year's meeting, Experience New Horizons in Diabetes.
The American Society of Clinical Oncology (ASCO) will host its annual meeting on June 2-7, 2017, in Chicago, Illinois, at McCormick Place. The meeting will highlight the newest advances in caring for patients and survivors through the lens of this year's theme, Making a Difference in Cancer Care With You. Check back for biosimilars coverage at ASCO.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its 22nd Annual International Meeting in Boston, Massachusetts, from May 20-24, 2017. This year's meeting, Evidence and Value in a Time of Social and Policy Change, brought payers, researchers, and other stakeholders together to learn about drug development and regulatory issues in today's rapidly-changing healthcare environment, with several sessions on biologics and biosimilars. 
The annual meeting of the The American Academy of Allergy, Asthma & Immunology (AAAAI), brings together allergists, immunologists, allied health, and other healthcare professionals, and covers a variety of topics, including allergic disease, asthma, immunotherapy, practice management, and new technologies. The Center for Biosimilars is covering this meeting, held March 3-6, 2017, in Atlanta, GA.


Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2017 Intellisphere, LLC. All Rights Reserved.